anticoagulants Flashcards
unfractionated heparin MOA
binds to antithrombin III
inhibition of factor II and X
small platelet inhibition
unfractionated heparin/LMWH antidote
protamine
heparin monitoring and normal ranges
PTT - 50-80 sec (1.5-3x baseline is therapeutic)
anti Xa - 0.3-0.7 U/mL
adverse effects of heparin
bleeding
skin necrosis, HIT, altered bone metabolism
HIT diagnosis
antibody tests
4 T’s score
HIT treatment
argatroban
also fondaparinux and bivalrudin but not FDA approved
LMWH MOA
binds w antithrombin to inhibit factor X
mild inhibition of factor II
UFH vs LMWH
LMWH has more predictable response, less bleeding, no routine lab monitoring, able to be given as outpatient
dosing adjustment for LMWH
renal
bivalrudin MOA
direct thrombin inhibitor
dosing adjustment for bivalrudin
renal
bivalrudin dosing
0.1 mg/kg bolus, then 0.25 mg/kg/h
argatroban MOA
direct thrombin inhibitor
bivalrudin/argatroban monitoring
PTT
argatroban dosing
1.7-2.0 mcg/kg/min